Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Medtronic
AstraZeneca
Colorcon
Merck

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Impax Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for IMPAX PHARMS, and what generic and branded alternatives to IMPAX PHARMS drugs are available?

IMPAX PHARMS has seven approved drugs.

There is one tentative approval on IMPAX PHARMS drugs.

Summary for Impax Pharms
US Patents:0
Tradenames:7
Ingredients:7
NDAs:7

Drugs and US Patents for Impax Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Pharms GEMFIBROZIL gemfibrozil TABLET;ORAL 078207-001 Jun 1, 2007 AB RX No No   Start Trial   Start Trial
Impax Pharms FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076298-001 Nov 12, 2010 DISCN No No   Start Trial   Start Trial
Impax Pharms MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076449-001 May 27, 2004 AB RX No No   Start Trial   Start Trial
Impax Pharms OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 076745-001 Nov 9, 2006 AB RX No No   Start Trial   Start Trial
Impax Pharms SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075663-003 Nov 7, 2000 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Mallinckrodt
Harvard Business School
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.